General Practice · Glendale, CA
NPI
1124188628
Since 2006
Specialty
General Practice
Code 208D00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
800 S. Central Ave., Suite 308
Glendale, CA, 91204
Phone (818) 240-8767
Groups this clinician bills Medicare through
Medicare paid, 2024
$384K
6,612 services
Medicare patients, 2024
814
Average age 78
Drug cost, 2024
$3.6M
40,023 prescriptions
Company payments, 2025
$1,196
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Herach Yadegarian was code 99214 (office e&m - established), 2,475 times for 734 patients. In total Herach Yadegarian billed 6,612 services in 30 codes, and Medicare paid $384K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-09-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,475 | 734 | $88.11 | $218K |
| 36415 Venipuncture Blood Collection | Office | 1,542 | 706 | $8.65 | $13K |
| 99215 Office E&M - Established | Office | 648 | 282 | $128.82 | $83K |
| 82962 Clinical Chemistry | Office | 589 | 261 | $3.21 | $1,891 |
| 81002 Clinical Chemistry | Office | 330 | 247 | $3.41 | $1,125 |
| 99213 Office E&M - Established | Office | 217 | 152 | $61.90 | $13K |
| 99310 SNF E&M | Office | 207 | 58 | $115.09 | $24K |
| 96372 Injection Administration | Office | 101 | 49 | $10.86 | $1,097 |
| G0008 Administration of influenza virus vaccine | Office | 99 | 96 | $34.30 | $3,396 |
| 90656 Vaccine Product | Office | 95 | 95 | $21.90 | $2,081 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 56 | 51 | $40.51 | $2,269 |
| 93000 Electrocardiogram | Office | 53 | 48 | $11.15 | $591 |
| 99306 SNF E&M | Office | 34 | 33 | $135.89 | $4,620 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 32 | 29 | $31.07 | $994 |
| 99205 Office E&M - New | Office | 24 | 24 | $142.44 | $3,419 |
By year: 2022 $380K for 6,420 services; 2023 $425K for 7,261 services; 2024 $384K for 6,612 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,542 | 706 | $8.65 | $13K |
| 82962 Clinical Chemistry | 589 | 261 | $3.21 | $1,891 |
| 81002 Clinical Chemistry | 330 | 247 | $3.41 | $1,125 |
Medicare prescription drug claims, 2024
In 2024, the drug Herach Yadegarian prescribed most often to Medicare patients was Rosuvastatin Calcium, with 2,303 prescriptions and refills. In total Herach Yadegarian wrote 40,023 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 2,303 | 3,518 | 348 | $14K |
| Atorvastatin Calcium Generic | 1,575 | 2,301 | 221 | $7,881 |
| Amlodipine Besylate Generic | 1,307 | 1,932 | 190 | $3,390 |
| Levothyroxine Sodium Generic | 1,157 | 1,748 | 154 | $7,104 |
| Metoprolol Succinate Generic | 1,061 | 1,542 | 148 | $6,848 |
| Metformin Hcl Generic | 1,015 | 1,555 | 152 | $77K |
| Losartan Potassium Generic | 940 | 1,330 | 134 | $3,707 |
| Celecoxib Generic | 837 | 1,038 | 112 | $19K |
| Clonazepam Generic | 830 | 865 | 111 | $1,771 |
| Simvastatin Generic | 782 | 1,221 | 112 | $2,655 |
| Gabapentin Generic | 766 | 1,050 | 111 | $4,282 |
| Furosemide Generic | 679 | 891 | 105 | $2,345 |
| Dexlansoprazole Dr Dexlansoprazole | 663 | 979 | 112 | $160K |
| Omeprazole Generic | 647 | 957 | 110 | $2,715 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 563 | 835 | 85 | $3,740 |
Brand drugs: 5,024 claims; generic drugs: 34,295 claims; opioid claims: 286.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Herach Yadegarian $1,196 ($1,196 in general payments such as food, travel and fees) from 18 companies. The largest payer was Ardelyx, Inc. with $224.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 7 | $224 |
| Amgen Inc. AMGN | 13 | $211 |
| Lilly USA, LLC LLY | 5 | $125 |
| Abbvie Inc. ABBV | 5 | $114 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $98.15 |
| Lundbeck LLC | 3 | $77.45 |
| Almatica Pharma LLC | 2 | $50.22 |
| Kowa Pharmaceuticals America, Inc. | 2 | $45.94 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $35.95 |
| Shield Therapeutics Inc STX.L | 1 | $28.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.